Survey of Ophthalmology
Volume 50, Issue 4 , Pages 351-363, July 2005

Scleritis

  • Narciss Okhravi, PhD, FRCOphth

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, United Kingdom
  • ,
  • Bola Odufuwa, FRCOphth

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, United Kingdom
  • ,
  • Peter McCluskey, MD, FRCS

      Affiliations

    • Department of Ophthalmology, Royal Prince Alfred Hospital, Missenden Road, Camperdown, New South Wales, 2050, Australia
  • ,
  • Susan Lightman, PhD, FRCOphth

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, United Kingdom
    • Corresponding Author InformationReprint address: Professor Susan Lightman, Department of Clinical Ophthalmology, Moorfields Eye Hospital, City Road, London EC1V 2PD, UK.

Abstract 

Scleritis is typically a severe painful inflammatory process centered in the sclera that may involve the cornea, adjacent episclera, and underlying uvea; it poses a significant threat to vision. Careful clinical history taking, detailed ocular examination, appropriate investigation for ocular disease with or without underlying systemic disease, and timely intervention with the use of immunosuppressant drugs when necessary, has improved the long-term outcome for patients with this disease.

Key words: autoimmune, episcleritis, infectious, masquerade, necrotizing, nodular, scleritis, scleromalacia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(05)00039-1

doi:10.1016/j.survophthal.2005.04.001

Survey of Ophthalmology
Volume 50, Issue 4 , Pages 351-363, July 2005